Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open Label Clinical Pilot Study of Resveratrol as Treatment for Friedreich Ataxia

NCT01339884 is registered in ClinicalTrials.gov with Murdoch Childrens Research Institute as lead sponsor.

NCT NCT01339884
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01339884 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open Label Clinical Pilot Study of Resveratrol as Treatment for Friedreich Ataxia
Lead sponsor
Murdoch Childrens Research Institute
Phase
Phase 1/2
Overall status
Completed
Start date
April 30, 2011
Completion date
December 31, 2012
Enrollment
27 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

friedreich ataxia